The World Market for Natural or Synthetic Hormones, Hormone Derivatives, and Other Steriods Used As Hormones Excluding Medicaments: A 2021 Global Trade Perspective

The World Market for Natural or Synthetic Hormones, Hormone Derivatives, and Other Steriods Used As Hormones Excluding Medicaments: A 2021 Global Trade Perspective

This series was created for international firms who rely on foreign export markets for a substantial portion of their business or who might be threatened by foreign trade competition. The estimates given in this report were created using a methodology developed by and under the direct supervision of Professor Philip M. Parker, the Chair Professor of Management Science at INSEAD. The methodology relies on historical figures of economic growth and trade flows of some 150 countries for over 2,500 industrial or product categories. The figures should be seen as market estimates, as opposed to historical records, as these are projected for the current year of trade.

On the demand side, exporters and strategic planners approaching the world market face a number of questions. Which countries are supplying natural or synthetic hormones, hormone derivatives, and other steriods used as hormones excluding medicaments? What is the dollar value of these imports? How much do the imports of natural or synthetic hormones, hormone derivatives, and other steriods used as hormones excluding medicaments vary from one country to another? Do exporters serving the world market have similar market shares across the importing countries? Which countries supply the most exports of natural or synthetic hormones, hormone derivatives, and other steriods used as hormones excluding medicaments? Which countries are buying their exports? What is the value of these exports and which countries are the largest buyers?

Natural or synthetic hormones, hormone derivatives, and other steriods used as hormones excluding medicaments as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defines natural or synthetic hormones, hormone derivatives, and other steriods used as hormones excluding medicaments is 5415.


1 METHODOLOGY
1.1 OUR APPROACH
2 THE WORLD MARKET
2.1 EXPORTS
2.1.1 THE WORLD MARKET: NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STERIODS USED AS HORMONES EXCLUDING MEDICAMENTS EXPORT SUPPLIES IN 2021
2.2 IMPORTS
2.2.1 THE WORLD MARKET: IMPORTED NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STERIODS USED AS HORMONES EXCLUDING MEDICAMENTS IN 2021
3 EXPORTS
3.1 AFRICA: EXPORT SUPPLIES OF NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STERIODS USED AS HORMONES EXCLUDING MEDICAMENTS IN 2021
3.1.1 EXECUTIVE SUMMARY
3.1.2 CAMEROON
3.1.3 SOUTH AFRICA
3.1.4 SWAZILAND
3.2 ASIA: EXPORT SUPPLIES OF NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STERIODS USED AS HORMONES EXCLUDING MEDICAMENTS IN 2021
3.2.1 EXECUTIVE SUMMARY
3.2.2 CHINA
3.2.3 HONG KONG
3.2.4 INDIA
3.2.5 INDONESIA
3.2.6 JAPAN
3.2.7 MALAYSIA
3.2.8 PHILIPPINES
3.2.9 SINGAPORE
3.2.10 SOUTH KOREA
3.2.11 TAIWAN
3.2.12 THAILAND
3.3 EUROPE: EXPORT SUPPLIES OF NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STERIODS USED AS HORMONES EXCLUDING MEDICAMENTS IN 2021
3.3.1 EXECUTIVE SUMMARY
3.3.2 AUSTRIA
3.3.3 BELGIUM
3.3.4 BULGARIA
3.3.5 CROATIA
3.3.6 CYPRUS
3.3.7 CZECH REPUBLIC
3.3.8 DENMARK
3.3.9 FINLAND
3.3.10 FRANCE
3.3.11 GEORGIA
3.3.12 GERMANY
3.3.13 GREECE
3.3.14 HUNGARY
3.3.15 IRELAND
3.3.16 ITALY
3.3.17 LATVIA
3.3.18 LITHUANIA
3.3.19 LUXEMBOURG
3.3.20 MALTA
3.3.21 NORWAY
3.3.22 POLAND
3.3.23 PORTUGAL
3.3.24 ROMANIA
3.3.25 RUSSIA
3.3.26 SPAIN
3.3.27 SWEDEN
3.3.28 SWITZERLAND
3.3.29 THE NETHERLANDS
3.3.30 THE UNITED KINGDOM
3.4 LATIN AMERICA: EXPORT SUPPLIES OF NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STERIODS USED AS HORMONES EXCLUDING MEDICAMENTS IN 2021
3.4.1 EXECUTIVE SUMMARY
3.4.2 ARGENTINA
3.4.3 BRAZIL
3.4.4 COLOMBIA
3.4.5 COSTA RICA
3.4.6 EL SALVADOR
3.4.7 MEXICO
3.4.8 PANAMA
3.4.9 PARAGUAY
3.4.10 URUGUAY
3.5 NORTH AMERICA & THE CARIBBEAN: EXPORT SUPPLIES OF NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STERIODS USED AS HORMONES EXCLUDING MEDICAMENTS IN 2021
3.5.1 EXECUTIVE SUMMARY
3.5.2 BERMUDA
3.5.3 CANADA
3.5.4 CUBA
3.5.5 THE UNITED STATES
3.6 OCEANIA: EXPORT SUPPLIES OF NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STERIODS USED AS HORMONES EXCLUDING MEDICAMENTS IN 2021
3.6.1 EXECUTIVE SUMMARY
3.6.2 AUSTRALIA
3.6.3 NEW ZEALAND
3.7 THE MIDDLE EAST: EXPORT SUPPLIES OF NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STERIODS USED AS HORMONES EXCLUDING MEDICAMENTS IN 2021
3.7.1 EXECUTIVE SUMMARY
3.7.2 IRAN
3.7.3 ISRAEL
3.7.4 PAKISTAN
3.7.5 SAUDI ARABIA
3.7.6 THE UNITED ARAB EMIRATES
3.7.7 TURKEY
4 IMPORTS
4.1 AFRICA: NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STERIODS USED AS HORMONES EXCLUDING MEDICAMENTS IMPORTS IN 2021
4.1.1 EXECUTIVE SUMMARY
4.1.2 ALGERIA
4.1.3 EGYPT
4.1.4 ETHIOPIA
4.1.5 MOROCCO
4.1.6 NAMIBIA
4.1.7 NIGERIA
4.1.8 SOUTH AFRICA
4.1.9 UGANDA
4.1.10 ZIMBABWE
4.2 ASIA: NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STERIODS USED AS HORMONES EXCLUDING MEDICAMENTS IMPORTS IN 2021
4.2.1 EXECUTIVE SUMMARY
4.2.2 BRUNEI
4.2.3 CHINA
4.2.4 HONG KONG
4.2.5 INDIA
4.2.6 INDONESIA
4.2.7 JAPAN
4.2.8 MALAYSIA
4.2.9 NEPAL
4.2.10 PHILIPPINES
4.2.11 SINGAPORE
4.2.12 SOUTH KOREA
4.2.13 SRI LANKA
4.2.14 TAIWAN
4.2.15 THAILAND
4.2.16 VIETNAM
4.3 EUROPE: NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STERIODS USED AS HORMONES EXCLUDING MEDICAMENTS IMPORTS IN 2021
4.3.1 EXECUTIVE SUMMARY
4.3.2 ANDORRA
4.3.3 AUSTRIA
4.3.4 BELARUS
4.3.5 BELGIUM
4.3.6 BOSNIA AND HERZEGOVINA
4.3.7 BULGARIA
4.3.8 CROATIA
4.3.9 CYPRUS
4.3.10 CZECH REPUBLIC
4.3.11 DENMARK
4.3.12 ESTONIA
4.3.13 FINLAND
4.3.14 FRANCE
4.3.15 GEORGIA
4.3.16 GERMANY
4.3.17 GREECE
4.3.18 HUNGARY
4.3.19 IRELAND
4.3.20 ITALY
4.3.21 KAZAKHSTAN
4.3.22 LATVIA
4.3.23 LITHUANIA
4.3.24 LUXEMBOURG
4.3.25 MALTA
4.3.26 MOLDOVA
4.3.27 NORWAY
4.3.28 POLAND
4.3.29 PORTUGAL
4.3.30 ROMANIA
4.3.31 RUSSIA
4.3.32 SLOVAKIA
4.3.33 SLOVENIA
4.3.34 SPAIN
4.3.35 SWEDEN
4.3.36 SWITZERLAND
4.3.37 THE NETHERLANDS
4.3.38 THE UNITED KINGDOM
4.3.39 UKRAINE
4.4 LATIN AMERICA: NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STERIODS USED AS HORMONES EXCLUDING MEDICAMENTS IMPORTS IN 2021
4.4.1 EXECUTIVE SUMMARY
4.4.2 ARGENTINA
4.4.3 BELIZE
4.4.4 BOLIVIA
4.4.5 BRAZIL
4.4.6 CHILE
4.4.7 COLOMBIA
4.4.8 ECUADOR
4.4.9 EL SALVADOR
4.4.10 GUATEMALA
4.4.11 HONDURAS
4.4.12 MEXICO
4.4.13 NICARAGUA
4.4.14 PARAGUAY
4.4.15 PERU
4.4.16 SURINAME
4.4.17 URUGUAY
4.5 NORTH AMERICA & THE CARIBBEAN: NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STERIODS USED AS HORMONES EXCLUDING MEDICAMENTS IMPORTS IN 2021
4.5.1 EXECUTIVE SUMMARY
4.5.2 CANADA
4.5.3 DOMINICAN REPUBLIC
4.5.4 THE UNITED STATES
4.6 OCEANIA: NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STERIODS USED AS HORMONES EXCLUDING MEDICAMENTS IMPORTS IN 2021
4.6.1 EXECUTIVE SUMMARY
4.6.2 AUSTRALIA
4.6.3 NEW ZEALAND
4.7 THE MIDDLE EAST: NATURAL OR SYNTHETIC HORMONES, HORMONE DERIVATIVES, AND OTHER STERIODS USED AS HORMONES EXCLUDING MEDICAMENTS IMPORTS IN 2021
4.7.1 EXECUTIVE SUMMARY
4.7.2 BAHRAIN
4.7.3 ISRAEL
4.7.4 JORDAN
4.7.5 KUWAIT
4.7.6 LEBANON
4.7.7 OMAN
4.7.8 PAKISTAN
4.7.9 QATAR
4.7.10 TURKEY
4.7.11 YEMEN
5 DISCLAIMERS, WARRANTIES, AND USER AGREEMENT PROVISIONS
5.1 DISCLAIMERS & SAFE HARBOR
5.2 ICON GROUP INTERNATIONAL, INC. USER AGREEMENT PROVISIONS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook